Mario Štefanović

1.1k total citations
85 papers, 859 citations indexed

About

Mario Štefanović is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Mario Štefanović has authored 85 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Organic Chemistry. Recurrent topics in Mario Štefanović's work include Sesquiterpenes and Asteraceae Studies (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Natural product bioactivities and synthesis (5 papers). Mario Štefanović is often cited by papers focused on Sesquiterpenes and Asteraceae Studies (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Natural product bioactivities and synthesis (5 papers). Mario Štefanović collaborates with scholars based in Croatia, Serbia and China. Mario Štefanović's co-authors include Elizabeta Topić, Ana-Maria Šimundić, Slobodan Milosavljević, Dalibor Karlović, Aleksandar Jokić, Nora Nikolac, Dejan Jeremić, Vida Demarin, Vanja M. Bulatović and Irena Žuntar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mario Štefanović

80 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Štefanović Croatia 16 266 128 101 100 92 85 859
Naheed Fatima Pakistan 18 407 1.5× 45 0.4× 153 1.5× 52 0.5× 131 1.4× 52 931
Angie Stone United States 19 628 2.4× 137 1.1× 49 0.5× 148 1.5× 46 0.5× 24 1.3k
Mudasir Maqbool India 19 354 1.3× 56 0.4× 242 2.4× 49 0.5× 37 0.4× 102 1.3k
Krishna B. Singh United States 20 323 1.2× 140 1.1× 86 0.9× 44 0.4× 99 1.1× 49 921
Yaoyao Bian China 20 361 1.4× 74 0.6× 94 0.9× 30 0.3× 38 0.4× 57 1.1k
Hui Xiao China 14 370 1.4× 85 0.7× 56 0.6× 40 0.4× 19 0.2× 42 1.3k
Koichi Handa Japan 19 381 1.4× 68 0.5× 25 0.2× 92 0.9× 34 0.4× 48 1.1k
G. Martin Benson United Kingdom 21 382 1.4× 101 0.8× 59 0.6× 39 0.4× 20 0.2× 49 1.4k
Reza Ahmadi Iran 19 275 1.0× 130 1.0× 124 1.2× 27 0.3× 39 0.4× 61 871
Cong Huai China 14 493 1.9× 81 0.6× 44 0.4× 242 2.4× 44 0.5× 30 1.0k

Countries citing papers authored by Mario Štefanović

Since Specialization
Citations

This map shows the geographic impact of Mario Štefanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Štefanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Štefanović more than expected).

Fields of papers citing papers by Mario Štefanović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Štefanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Štefanović. The network helps show where Mario Štefanović may publish in the future.

Co-authorship network of co-authors of Mario Štefanović

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Štefanović. A scholar is included among the top collaborators of Mario Štefanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Štefanović. Mario Štefanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Štefanović, Mario, Donatella Verbanac, Ivana Ćelap, et al.. (2024). MicroRNA-193a-3p as a Valuable Biomarker for Discriminating between Colorectal Cancer and Colorectal Adenoma Patients. International Journal of Molecular Sciences. 25(15). 8156–8156.
3.
Štefanović, Mario, Milica Velimirović, Tatjana Nikolić, et al.. (2023). 8-Iso-prostaglandin F2α as a potential biomarker in patients with unipolar and bipolar depression.. PubMed. 27(23). 11496–11507. 1 indexed citations
4.
Štefanović, Mario, et al.. (2023). Chronic Urticaria Biomarkers IL-6, ESR and CRP in Correlation with Disease Severity and Patient Quality of Life—A Pilot Study. Biomedicines. 11(8). 2232–2232. 7 indexed citations
5.
Miler, Marijana, Nora Nikolac, Ivana Ćelap, et al.. (2021). Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy. Rheumatology International. 41(12). 2195–2203. 6 indexed citations
6.
Štefanović, Mario, et al.. (2021). Long acting aripiprazole influences cognitive functions in recent onset schizophrenia. Psychopharmacology. 238(6). 1563–1573. 12 indexed citations
7.
Štefanović, Mario, et al.. (2020). Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case–control study. Indian Journal of Psychiatry. 62(1). 80–80. 7 indexed citations
9.
Štefanović, Mario, et al.. (2016). Comparison of HE4 and CA125 levels in women with benign gynecologic disorders. Wiener klinische Wochenschrift. 128(S7). 543–547. 2 indexed citations
10.
Štefanović, Mario, et al.. (2014). Serotonin transporter polymorphism (5-HTTLPR) in Croatian population. Molecular Biology Reports. 42(2). 553–558. 5 indexed citations
11.
Nikolac, Nora, et al.. (2008). Rare TA repeats in promoter TATA box of the UDP glucuronosyltranferase (UGT1A1) gene in Croatian subjects. Clinical Chemistry and Laboratory Medicine (CCLM). 46(2). 174–8. 9 indexed citations
12.
Šimundić, Ana-Maria, et al.. (2007). The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: The Croatian case–control study. Clinical Biochemistry. 40(13-14). 981–985. 45 indexed citations
13.
Topić, Elizabeta, et al.. (2004). Novi biokemijski biljezi u procjeni malog oštećenja miokarda u životno ugroženih bolesnika. 58. 381–388. 2 indexed citations
14.
Begonja, Antonija Jurak, Ana-Maria Šimundić, Mario Štefanović, & Elizabeta Topić. (2002). PCR-SSCP genotyping of the plasminogen activator inhibitor-1 4G/5G polymorphism. Biochemia Medica. 12. 1–5. 1 indexed citations
15.
Topić, Elizabeta, et al.. (2001). CYP2D6 polymorphism and side effects in schizophrenia and schizoaffective psychosis. Periodicum Biologorum. 103(4). 315–319. 2 indexed citations
16.
Topić, Elizabeta, Ana-Maria Šimundić, Mario Štefanović, et al.. (2001). Polymorphism of Apoprotein E (APOE), Methylenetetrahydrofolate Reductase (MTHFR) and Paraoxonase (PON1) Genes in Patients with Cerebrovascular Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 39(4). 346–50. 41 indexed citations
17.
Topić, Elizabeta, et al.. (2000). CYP2D6 Genotyping in Patients on Psychoactive Drug Therapy. Clinical Chemistry and Laboratory Medicine (CCLM). 38(9). 921–927. 19 indexed citations
18.
Topić, Elizabeta, et al.. (1998). Detection of CYP2D6*3 and 2D6*4 Allelic Variants by PCR-Restriction Fragment Length Polymorphism. Clinical Chemistry and Laboratory Medicine (CCLM). 36(8). 655–658. 10 indexed citations
19.
Todorović, Nina, et al.. (1996). Steroidal geminal dihydroperoxides and 1,2,4,5-tetraoxanes: Structure determination and their antimalarial activity. Steroids. 61(12). 688–696. 54 indexed citations
20.
Štefanović, Mario, et al.. (1994). Sesquiterpene lactones from Laserpitium latifolium. Fitoterapia. 65(6). 556. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026